A blood-based miRNA signature with prognostic value for overall survival in advanced stage non-small cell lung cancer treated with immunotherapy

Immunotherapies have recently gained traction as highly effective therapies in a subset of late-stage cancers. Unfortunately, only a minority of patients experience the remarkable benefits of immunotherapies, whilst others fail to respond or even come to harm through immune-related adverse events. F...

Full description

Saved in:
Bibliographic Details
Main Authors: Rajakumar, Timothy (Author) , Horos, Rastislav (Author) , Jehn, Julia (Author) , Schenz, Judith (Author) , Muley, Thomas (Author) , Pelea, Oana (Author) , Hofmann, Sarah (Author) , Kittner, Paul (Author) , Kahraman, Mustafa (Author) , Heuvelman, Marco (Author) , Sikosek, Tobias (Author) , Feufel, Jennifer (Author) , Skottke, Jasmin (Author) , Nötzel, Dennis (Author) , Hinkfoth, Franziska (Author) , Tikk, Kaja (Author) , Daniel-Moreno, Alberto (Author) , Ceiler, Jessika (Author) , Mercaldo, Nathaniel (Author) , Uhle, Florian (Author) , Uhle, Sandra (Author) , Weigand, Markus A. (Author) , Elshiaty, Mariam (Author) , Lusky, Fabienne (Author) , Schindler, Hannah (Author) , Ferry, Quentin (Author) , Sauka-Spengler, Tatjana (Author) , Wu, Qianxin (Author) , Rabe, Klaus F. (Author) , Reck, Martin (Author) , Thomas, Michael (Author) , Christopoulos, Petros (Author) , Steinkraus, Bruno R. (Author)
Format: Article (Journal)
Language:English
Published: 31 March 2022
In: npj precision oncology
Year: 2022, Volume: 6, Pages: 1-13
ISSN:2397-768X
DOI:10.1038/s41698-022-00262-y
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1038/s41698-022-00262-y
Verlag, lizenzpflichtig, Volltext: https://www.nature.com/articles/s41698-022-00262-y
Get full text
Author Notes:Timothy Rajakumar, Rastislav Horos, Julia Jehn, Judith Schenz, Thomas Muley, Oana Pelea, Sarah Hofmann, Paul Kittner, Mustafa Kahraman, Marco Heuvelman, Tobias Sikosek, Jennifer Feufel, Jasmin Skottke, Dennis Nötzel, Franziska Hinkfoth, Kaja Tikk, Alberto Daniel-Moreno, Jessika Ceiler, Nathaniel Mercaldo, Florian Uhle, Sandra Uhle, Markus A. Weigand, Mariam Elshiaty, Fabienne Lusky, Hannah Schindler, Quentin Ferry, Tatjana Sauka-Spengler, Qianxin Wu, Klaus F. Rabe, Martin Reck, Michael Thomas, Petros Christopoulos, Bruno R. Steinkraus

MARC

LEADER 00000caa a2200000 c 4500
001 181782841X
003 DE-627
005 20230118143556.0
007 cr uuu---uuuuu
008 220929s2022 xx |||||o 00| ||eng c
024 7 |a 10.1038/s41698-022-00262-y  |2 doi 
035 |a (DE-627)181782841X 
035 |a (DE-599)KXP181782841X 
035 |a (OCoLC)1361696004 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Rajakumar, Timothy  |e VerfasserIn  |0 (DE-588)1269157655  |0 (DE-627)1817830414  |4 aut 
245 1 2 |a A blood-based miRNA signature with prognostic value for overall survival in advanced stage non-small cell lung cancer treated with immunotherapy  |c Timothy Rajakumar, Rastislav Horos, Julia Jehn, Judith Schenz, Thomas Muley, Oana Pelea, Sarah Hofmann, Paul Kittner, Mustafa Kahraman, Marco Heuvelman, Tobias Sikosek, Jennifer Feufel, Jasmin Skottke, Dennis Nötzel, Franziska Hinkfoth, Kaja Tikk, Alberto Daniel-Moreno, Jessika Ceiler, Nathaniel Mercaldo, Florian Uhle, Sandra Uhle, Markus A. Weigand, Mariam Elshiaty, Fabienne Lusky, Hannah Schindler, Quentin Ferry, Tatjana Sauka-Spengler, Qianxin Wu, Klaus F. Rabe, Martin Reck, Michael Thomas, Petros Christopoulos, Bruno R. Steinkraus 
264 1 |c 31 March 2022 
300 |a 13 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Published: 31 March 2022 
500 |a Gesehen am 29.09.2022 
520 |a Immunotherapies have recently gained traction as highly effective therapies in a subset of late-stage cancers. Unfortunately, only a minority of patients experience the remarkable benefits of immunotherapies, whilst others fail to respond or even come to harm through immune-related adverse events. For immunotherapies within the PD-1/PD-L1 inhibitor class, patient stratification is currently performed using tumor (tissue-based) PD-L1 expression. However, PD-L1 is an accurate predictor of response in only ~30% of cases. There is pressing need for more accurate biomarkers for immunotherapy response prediction. We sought to identify peripheral blood biomarkers, predictive of response to immunotherapies against lung cancer, based on whole blood microRNA profiling. Using three well-characterized cohorts consisting of a total of 334 stage IV NSCLC patients, we have defined a 5 microRNA risk score (miRisk) that is predictive of overall survival following immunotherapy in training and independent validation (HR 2.40, 95% CI 1.37-4.19; P < 0.01) cohorts. We have traced the signature to a myeloid origin and performed miRNA target prediction to make a direct mechanistic link to the PD-L1 signaling pathway and PD-L1 itself. The miRisk score offers a potential blood-based companion diagnostic for immunotherapy that outperforms tissue-based PD-L1 staining. 
650 4 |a Cancer immunotherapy 
650 4 |a Non-coding RNAs 
650 4 |a Non-small-cell lung cancer 
700 1 |a Horos, Rastislav  |e VerfasserIn  |4 aut 
700 1 |a Jehn, Julia  |e VerfasserIn  |4 aut 
700 1 |a Schenz, Judith  |e VerfasserIn  |0 (DE-588)1163038768  |0 (DE-627)1027280935  |0 (DE-576)507754875  |4 aut 
700 1 |a Muley, Thomas  |e VerfasserIn  |0 (DE-588)1056885432  |0 (DE-627)794179169  |0 (DE-576)16759284X  |4 aut 
700 1 |a Pelea, Oana  |e VerfasserIn  |4 aut 
700 1 |a Hofmann, Sarah  |e VerfasserIn  |4 aut 
700 1 |a Kittner, Paul  |e VerfasserIn  |4 aut 
700 1 |a Kahraman, Mustafa  |e VerfasserIn  |4 aut 
700 1 |a Heuvelman, Marco  |e VerfasserIn  |4 aut 
700 1 |a Sikosek, Tobias  |d 1979-  |e VerfasserIn  |0 (DE-588)1027778542  |0 (DE-627)729713601  |0 (DE-576)37529838X  |4 aut 
700 1 |a Feufel, Jennifer  |e VerfasserIn  |4 aut 
700 1 |a Skottke, Jasmin  |e VerfasserIn  |4 aut 
700 1 |a Nötzel, Dennis  |e VerfasserIn  |4 aut 
700 1 |a Hinkfoth, Franziska  |e VerfasserIn  |4 aut 
700 1 |a Tikk, Kaja  |e VerfasserIn  |4 aut 
700 1 |a Daniel-Moreno, Alberto  |e VerfasserIn  |4 aut 
700 1 |a Ceiler, Jessika  |e VerfasserIn  |4 aut 
700 1 |a Mercaldo, Nathaniel  |e VerfasserIn  |4 aut 
700 1 |a Uhle, Florian  |e VerfasserIn  |0 (DE-588)106860560X  |0 (DE-627)820511730  |0 (DE-576)427922534  |4 aut 
700 1 |a Uhle, Sandra  |e VerfasserIn  |0 (DE-588)1072524775  |0 (DE-627)827682395  |0 (DE-576)433998628  |4 aut 
700 1 |a Weigand, Markus A.  |d 1967-  |e VerfasserIn  |0 (DE-588)1064970435  |0 (DE-627)815375239  |0 (DE-576)424658666  |4 aut 
700 1 |a Elshiaty, Mariam  |e VerfasserIn  |0 (DE-588)1237666333  |0 (DE-627)1764596110  |4 aut 
700 1 |a Lusky, Fabienne  |d 1998-  |e VerfasserIn  |0 (DE-588)1269158120  |0 (DE-627)1817831615  |4 aut 
700 1 |a Schindler, Hannah  |d 1998-  |e VerfasserIn  |0 (DE-588)1237666503  |0 (DE-627)1764596366  |4 aut 
700 1 |a Ferry, Quentin  |e VerfasserIn  |4 aut 
700 1 |a Sauka-Spengler, Tatjana  |e VerfasserIn  |4 aut 
700 1 |a Wu, Qianxin  |e VerfasserIn  |4 aut 
700 1 |a Rabe, Klaus F.  |e VerfasserIn  |4 aut 
700 1 |a Reck, Martin  |e VerfasserIn  |4 aut 
700 1 |a Thomas, Michael  |e VerfasserIn  |0 (DE-588)1054438781  |0 (DE-627)79152213X  |0 (DE-576)41027089X  |4 aut 
700 1 |a Christopoulos, Petros  |d 1977-  |e VerfasserIn  |0 (DE-588)138659702  |0 (DE-627)604886756  |0 (DE-576)308488067  |4 aut 
700 1 |a Steinkraus, Bruno R.  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t npj precision oncology  |d [London] : Springer Nature, 2017  |g 6(2022), Artikel-ID 19, Seite 1-13  |h Online-Ressource  |w (DE-627)884384454  |w (DE-600)2891458-2  |w (DE-576)486547728  |x 2397-768X  |7 nnas  |a A blood-based miRNA signature with prognostic value for overall survival in advanced stage non-small cell lung cancer treated with immunotherapy 
773 1 8 |g volume:6  |g year:2022  |g elocationid:19  |g pages:1-13  |g extent:13  |a A blood-based miRNA signature with prognostic value for overall survival in advanced stage non-small cell lung cancer treated with immunotherapy 
856 4 0 |u https://doi.org/10.1038/s41698-022-00262-y  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.nature.com/articles/s41698-022-00262-y  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20220929 
993 |a Article 
994 |a 2022 
998 |g 138659702  |a Christopoulos, Petros  |m 138659702:Christopoulos, Petros  |d 910000  |d 950000  |d 950900  |d 50000  |e 910000PC138659702  |e 950000PC138659702  |e 950900PC138659702  |e 50000PC138659702  |k 0/910000/  |k 1/910000/950000/  |k 2/910000/950000/950900/  |k 0/50000/  |p 32 
998 |g 1054438781  |a Thomas, Michael  |m 1054438781:Thomas, Michael  |d 910000  |d 950000  |d 950900  |d 50000  |e 910000PT1054438781  |e 950000PT1054438781  |e 950900PT1054438781  |e 50000PT1054438781  |k 0/910000/  |k 1/910000/950000/  |k 2/910000/950000/950900/  |k 0/50000/  |p 31 
998 |g 1237666503  |a Schindler, Hannah  |m 1237666503:Schindler, Hannah  |d 50000  |e 50000PS1237666503  |k 0/50000/  |p 25 
998 |g 1269158120  |a Lusky, Fabienne  |m 1269158120:Lusky, Fabienne  |d 50000  |e 50000PL1269158120  |k 0/50000/  |p 24 
998 |g 1237666333  |a Elshiaty, Mariam  |m 1237666333:Elshiaty, Mariam  |d 50000  |e 50000PE1237666333  |k 0/50000/  |p 23 
998 |g 1064970435  |a Weigand, Markus A.  |m 1064970435:Weigand, Markus A.  |d 910000  |d 910300  |d 50000  |e 910000PW1064970435  |e 910300PW1064970435  |e 50000PW1064970435  |k 0/910000/  |k 1/910000/910300/  |k 0/50000/  |p 22 
998 |g 1072524775  |a Uhle, Sandra  |m 1072524775:Uhle, Sandra  |d 910000  |d 910300  |e 910000PU1072524775  |e 910300PU1072524775  |k 0/910000/  |k 1/910000/910300/  |p 21 
998 |g 106860560X  |a Uhle, Florian  |m 106860560X:Uhle, Florian  |d 910000  |d 910300  |e 910000PU106860560X  |e 910300PU106860560X  |k 0/910000/  |k 1/910000/910300/  |p 20 
998 |g 1056885432  |a Muley, Thomas  |m 1056885432:Muley, Thomas  |d 910000  |d 950000  |d 950900  |e 910000PM1056885432  |e 950000PM1056885432  |e 950900PM1056885432  |k 0/910000/  |k 1/910000/950000/  |k 2/910000/950000/950900/  |p 5 
998 |g 1163038768  |a Schenz, Judith  |m 1163038768:Schenz, Judith  |d 910000  |d 910300  |e 910000PS1163038768  |e 910300PS1163038768  |k 0/910000/  |k 1/910000/910300/  |p 4 
999 |a KXP-PPN181782841X  |e 4193473538 
BIB |a Y 
SER |a journal 
JSO |a {"recId":"181782841X","relHost":[{"note":["Gesehen am 20. April 2017"],"origin":[{"publisher":"Springer Nature","dateIssuedDisp":"[2017]-","publisherPlace":"[London]"}],"pubHistory":["20 March 2017-"],"recId":"884384454","name":{"displayForm":["published by Springer Nature in partnership with The Hormel Institute, University of Minnesota"]},"language":["eng"],"id":{"issn":["2397-768X"],"zdb":["2891458-2"],"eki":["884384454"]},"titleAlt":[{"title":"a nature research journal"},{"title":"Precision oncology"}],"type":{"media":"Online-Ressource","bibl":"periodical"},"title":[{"subtitle":"a natureresearch journal","title_sort":"npj precision oncology","title":"npj precision oncology"}],"part":{"extent":"13","volume":"6","text":"6(2022), Artikel-ID 19, Seite 1-13","pages":"1-13","year":"2022"},"physDesc":[{"extent":"Online-Ressource"}],"disp":"A blood-based miRNA signature with prognostic value for overall survival in advanced stage non-small cell lung cancer treated with immunotherapynpj precision oncology"}],"origin":[{"dateIssuedKey":"2022","dateIssuedDisp":"31 March 2022"}],"note":["Published: 31 March 2022","Gesehen am 29.09.2022"],"person":[{"family":"Rajakumar","role":"aut","display":"Rajakumar, Timothy","given":"Timothy"},{"role":"aut","given":"Rastislav","display":"Horos, Rastislav","family":"Horos"},{"family":"Jehn","role":"aut","given":"Julia","display":"Jehn, Julia"},{"family":"Schenz","role":"aut","display":"Schenz, Judith","given":"Judith"},{"family":"Muley","role":"aut","display":"Muley, Thomas","given":"Thomas"},{"role":"aut","display":"Pelea, Oana","given":"Oana","family":"Pelea"},{"role":"aut","given":"Sarah","display":"Hofmann, Sarah","family":"Hofmann"},{"role":"aut","display":"Kittner, Paul","given":"Paul","family":"Kittner"},{"family":"Kahraman","given":"Mustafa","display":"Kahraman, Mustafa","role":"aut"},{"role":"aut","given":"Marco","display":"Heuvelman, Marco","family":"Heuvelman"},{"given":"Tobias","display":"Sikosek, Tobias","role":"aut","family":"Sikosek"},{"family":"Feufel","role":"aut","given":"Jennifer","display":"Feufel, Jennifer"},{"role":"aut","display":"Skottke, Jasmin","given":"Jasmin","family":"Skottke"},{"role":"aut","given":"Dennis","display":"Nötzel, Dennis","family":"Nötzel"},{"role":"aut","given":"Franziska","display":"Hinkfoth, Franziska","family":"Hinkfoth"},{"role":"aut","given":"Kaja","display":"Tikk, Kaja","family":"Tikk"},{"role":"aut","display":"Daniel-Moreno, Alberto","given":"Alberto","family":"Daniel-Moreno"},{"family":"Ceiler","given":"Jessika","display":"Ceiler, Jessika","role":"aut"},{"display":"Mercaldo, Nathaniel","given":"Nathaniel","role":"aut","family":"Mercaldo"},{"role":"aut","display":"Uhle, Florian","given":"Florian","family":"Uhle"},{"role":"aut","given":"Sandra","display":"Uhle, Sandra","family":"Uhle"},{"family":"Weigand","role":"aut","display":"Weigand, Markus A.","given":"Markus A."},{"role":"aut","given":"Mariam","display":"Elshiaty, Mariam","family":"Elshiaty"},{"role":"aut","given":"Fabienne","display":"Lusky, Fabienne","family":"Lusky"},{"family":"Schindler","display":"Schindler, Hannah","given":"Hannah","role":"aut"},{"family":"Ferry","role":"aut","display":"Ferry, Quentin","given":"Quentin"},{"family":"Sauka-Spengler","given":"Tatjana","display":"Sauka-Spengler, Tatjana","role":"aut"},{"display":"Wu, Qianxin","given":"Qianxin","role":"aut","family":"Wu"},{"family":"Rabe","role":"aut","display":"Rabe, Klaus F.","given":"Klaus F."},{"family":"Reck","role":"aut","display":"Reck, Martin","given":"Martin"},{"role":"aut","given":"Michael","display":"Thomas, Michael","family":"Thomas"},{"family":"Christopoulos","given":"Petros","display":"Christopoulos, Petros","role":"aut"},{"display":"Steinkraus, Bruno R.","given":"Bruno R.","role":"aut","family":"Steinkraus"}],"title":[{"title":"A blood-based miRNA signature with prognostic value for overall survival in advanced stage non-small cell lung cancer treated with immunotherapy","title_sort":"blood-based miRNA signature with prognostic value for overall survival in advanced stage non-small cell lung cancer treated with immunotherapy"}],"physDesc":[{"extent":"13 S."}],"id":{"eki":["181782841X"],"doi":["10.1038/s41698-022-00262-y"]},"name":{"displayForm":["Timothy Rajakumar, Rastislav Horos, Julia Jehn, Judith Schenz, Thomas Muley, Oana Pelea, Sarah Hofmann, Paul Kittner, Mustafa Kahraman, Marco Heuvelman, Tobias Sikosek, Jennifer Feufel, Jasmin Skottke, Dennis Nötzel, Franziska Hinkfoth, Kaja Tikk, Alberto Daniel-Moreno, Jessika Ceiler, Nathaniel Mercaldo, Florian Uhle, Sandra Uhle, Markus A. Weigand, Mariam Elshiaty, Fabienne Lusky, Hannah Schindler, Quentin Ferry, Tatjana Sauka-Spengler, Qianxin Wu, Klaus F. Rabe, Martin Reck, Michael Thomas, Petros Christopoulos, Bruno R. Steinkraus"]},"language":["eng"],"type":{"bibl":"article-journal","media":"Online-Ressource"}} 
SRT |a RAJAKUMARTBLOODBASED3120